Relative Bioavailability of an Investigational Single Dose of Dulaglutide After Subcutaneous Administration by a Single Dose Pen Compared to a Prefilled Syringe in Healthy Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 09 Apr 2018 Planned End Date changed from 1 Mar 2018 to 1 Jun 2018.
- 09 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Jun 2018.
- 19 Feb 2018 Status changed from recruiting to active, no longer recruiting.